ShortCuts-This Week in the Journals

November 19, 2007
ShortCuts-This Week in the Journals

Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations

As winter quickly approaches and we plunge into flu season, it’s fitting that news of a “killer” cold virus broke last week. According to a CDC report, adenovirus serotype 14 (Ad14) is an emerging strain of adenovirus that may cause severe respiratory illness and even death in people of all ages, including healthy young adults. The virus has been linked to 140 cases in 4 states (including NY) between 2006 and 2007. Over a…

Read more »

Treatment of obesity with bariatric surgery: evidence and implications

November 15, 2007
Treatment of obesity with bariatric surgery: evidence and implications

Commentary by Jatin Roper MD PGY-3 and Christine Ren MD Associate Professor, Department of Surgery

Bariatric procedures to treat obesity involve the restriction of the gastric reservoir, bypass of part of the gastrointestinal tract, or both. Worldwide, an estimated 300 million people are obese, and in the United States, the percentage of adults who are obese increased from 15% in 1995 to 24% in 2005. (Obesity is defined as a Body Mass Index or BMI of 30 or more, measured as kg /…

Read more »

FDA Approves Raltegravir- A First in New Class of HIV Medications

November 14, 2007
FDA Approves Raltegravir- A First in New Class of HIV Medications

Commentary by Helen Kourlas PharmD, Pharmacology Section Editor

On October 16th the FDA announced the approval of raltegravir (Isentress®) for the treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents. The use of raltegravir is recommended for patients who have HIV-1 strains resistant to multiple antiretroviral medications. Raltegravir belongs to a new pharmacologic class of antiretrovirals called HIV integrase strand transfer inhibitors. Integrase is one of the three enzymes necessary for the HIV-1 virus to replicate, and integrase inhibitors can stop the…

Read more »

ShortCuts-This Week in the Journals

November 13, 2007
ShortCuts-This Week in the Journals

Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program

Published early online in NEJM comes the CORONA study “Rosuvastatin in Older Patients with Systolic Heart Failure”. In this trial, 5000 patients with class II, III and IV ischemic, systolic heart failure were randomized to receive placebo or rosuvastatin 10 mg. In prior statin trials, patients with reduced ejection fractions were not included, so this trial is important for that reason. The results surprisingly revealed no significant differences between the…

Read more »

Grand Rounds: “Pseudomonas aeruginosa Pathogenesis-Studies of an Opportunist”

November 9, 2007
Grand Rounds: “Pseudomonas aeruginosa Pathogenesis-Studies of an Opportunist”

Welcome to our Grand Rounds Series. Each week, we plan to post a summary of the week’s Medicine Grand Rounds lecture. The summaries are reviewed and approved by the grand rounds speaker prior to posting.

Commentary by Ryan Farley MD, PGY-3

This week’s Medicine Grand Rounds guest lecturer was Dr. Barbara Kazmierczak , currently Associate Professor of Medicine and Microbial Pathogenesis at Yale University School of Medicine.  Dr. Kazmierczak is the principal investigator for several NIH grants studying Pseudomonas aeruginosa virulence…

Read more »

Inpatient Diabetes Management: Case 6

November 8, 2007
Inpatient Diabetes Management: Case 6

Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center

Welcome to Case 6 of our special diabetes series intended to highlight the essentials of diabetes care in the inpatient setting. Over the last several weeks, we have been presenting individual cases followed by some management questions and answers.

Case 6: The Case of Ms. Longshore

Ms. Longshore is a 21 year old female with type 1 diabetes who was admitted to the…

Read more »

Vagally-induced Atrial Fibrillation

November 7, 2007
Vagally-induced Atrial Fibrillation

Case by: Alana Choy-Shan, Chief Resident

Commentary by William Slater MD, Associate Professor of Medicine, Division of Cardiology

Following Thanksgiving dinner, a 36 year-old healthy man developed palpitations and heart racing. He was evaluated in the emergency room and was noted to be in atrial fibrillation with rapid ventricular response. All of his other vital signs were within normal limits. He was treated with a beta-blocker for rate control and was started on anticoagulation. Within a few hours, he spontaneously converted to normal…

Read more »

Clinical Pathology Conference 11/9/07

November 6, 2007
Clinical Pathology Conference 11/9/07

Case presentation by Shrujal Baxi MD, Chief Resident

Welcome to the monthly posting of our NYU Department of Medicine’s Clinical Pathology Conference. Use the links below to review the case and the radiological findings. Our faculty and medical students will be attempting to diagnose this unknown case Friday 11/9/07 in the 17 West Conference Room at Bellevue Hospital. Feel free to make your diagnosis by clicking the comment field below. For those who are unable to attend the live conference, we will reveal…

Read more »